Refractory, advanced Breast cancer

Also known as: Refractory advanced Breast cancer

DrugDrug NameDrug Description
DB01590EverolimusA mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies.
DB00990ExemestaneAn aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen.
DB00947FulvestrantAn estrogen receptor antagonist used to treat HR+ breast cancer that may also be HER2-.
DB01259LapatinibAn antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-negative breast cancer in patients who received prior chemotherapeutic treatments.
DB09073PalbociclibAn endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer.
DrugDrug NamePhaseStatusCount